First Trust Advisors LP Vertex Pharmaceuticals Inc Transaction History

First Trust Advisors LP

  • $101 Billion
  • Q3 2024

A detailed history of First Trust Advisors LP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, First Trust Advisors LP holds 575,032 shares of VRTX stock, worth $230 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
575,032
Previous 203,341 182.79%
Holding current value
$230 Million
Previous $95.3 Million 180.6%
% of portfolio
0.26%
Previous 0.1%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$460.0 - $505.78 $171 Million - $188 Million
371,691 Added 182.79%
575,032 $267 Million
Q2 2024

Aug 13, 2024
SELL
$392.81 - $485.53 $10.9 Million - $13.5 Million
-27,856 Reduced 12.05%
203,341 $95.3 Million
Q1 2024

May 13, 2024
SELL
$407.69 - $446.08 $205 Million - $225 Million
-503,638 Reduced 68.54%
231,197 $96.6 Million
Q4 2023

Feb 13, 2024
SELL
$343.0 - $410.68 $21.8 Million - $26.1 Million
-63,531 Reduced 7.96%
734,835 $299 Million
Q3 2023

Nov 13, 2023
BUY
$338.18 - $362.46 $172 Million - $184 Million
508,389 Added 175.32%
798,366 $278 Million
Q2 2023

Aug 14, 2023
SELL
$314.42 - $351.91 $13.5 Million - $15.1 Million
-42,809 Reduced 12.86%
289,977 $102 Million
Q1 2023

May 15, 2023
SELL
$283.23 - $323.1 $4.87 Million - $5.55 Million
-17,185 Reduced 4.91%
332,786 $105 Million
Q4 2022

Feb 09, 2023
SELL
$285.76 - $321.48 $3.12 Million - $3.51 Million
-10,921 Reduced 3.03%
349,971 $101 Million
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $183 Million - $204 Million
-668,540 Reduced 64.94%
360,892 $104 Million
Q2 2022

Aug 12, 2022
BUY
$234.96 - $292.55 $138 Million - $172 Million
588,620 Added 133.53%
1,029,432 $290 Million
Q1 2022

May 13, 2022
SELL
$221.42 - $260.97 $17.8 Million - $21 Million
-80,615 Reduced 15.46%
440,812 $115 Million
Q4 2021

Feb 08, 2022
BUY
$177.01 - $223.45 $5.44 Million - $6.87 Million
30,756 Added 6.27%
521,427 $115 Million
Q3 2021

Nov 15, 2021
BUY
$181.39 - $202.99 $16.6 Million - $18.5 Million
91,357 Added 22.88%
490,671 $89 Million
Q2 2021

Oct 12, 2021
SELL
$187.49 - $221.1 $131,617 - $155,212
-702 Reduced 0.18%
399,314 $80.5 Million
Q2 2021

Aug 16, 2021
BUY
$187.49 - $221.1 $2.33 Million - $2.75 Million
12,436 Added 3.21%
400,016 $80.7 Million
Q1 2021

May 14, 2021
SELL
$207.02 - $241.31 $3.4 Million - $3.97 Million
-16,439 Reduced 4.07%
387,580 $83.3 Million
Q4 2020

Feb 02, 2021
SELL
$207.01 - $276.09 $88.1 Million - $118 Million
-425,744 Reduced 51.31%
404,019 $95.5 Million
Q3 2020

Nov 05, 2020
BUY
$255.65 - $303.1 $4.53 Million - $5.37 Million
17,708 Added 2.18%
829,763 $226 Million
Q2 2020

Jul 22, 2020
BUY
$225.48 - $295.8 $71.4 Million - $93.7 Million
316,633 Added 63.91%
812,055 $236 Million
Q1 2020

May 06, 2020
BUY
$199.77 - $247.81 $27.7 Million - $34.3 Million
138,446 Added 38.78%
495,422 $118 Million
Q4 2019

Feb 03, 2020
SELL
$166.71 - $223.91 $14.9 Million - $20 Million
-89,458 Reduced 20.04%
356,976 $78.2 Million
Q3 2019

Nov 04, 2019
SELL
$166.23 - $187.09 $36.9 Million - $41.5 Million
-221,798 Reduced 33.19%
446,434 $75.6 Million
Q2 2019

Jul 30, 2019
SELL
$164.61 - $190.37 $11.4 Million - $13.2 Million
-69,332 Reduced 9.4%
668,232 $123 Million
Q1 2019

May 09, 2019
BUY
$163.73 - $194.7 $4.76 Million - $5.66 Million
29,086 Added 4.11%
737,564 $136 Million
Q4 2018

Feb 07, 2019
SELL
$151.91 - $192.21 $1.52 Million - $1.92 Million
-9,977 Reduced 1.39%
708,478 $117 Million
Q3 2018

Oct 25, 2018
BUY
$167.73 - $192.74 $34.3 Million - $39.5 Million
204,780 Added 39.87%
718,455 $138 Million
Q2 2018

Aug 02, 2018
BUY
$145.72 - $169.96 $5.35 Million - $6.24 Million
36,704 Added 7.7%
513,675 $87.3 Million
Q1 2018

Apr 23, 2018
SELL
$151.6 - $177.13 $9.92 Million - $11.6 Million
-65,461 Reduced 12.07%
476,971 $77.7 Million
Q4 2017

Feb 08, 2018
SELL
$137.28 - $155.55 $1.73 Million - $1.96 Million
-12,589 Reduced 2.27%
542,432 $81.3 Million
Q3 2017

Oct 24, 2017
BUY
$148.13 - $162.24 $82.2 Million - $90 Million
555,021
555,021 $84.4 Million

Others Institutions Holding VRTX

# of Institutions
1,725
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $103B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email